Other milder side effects include headache, dizziness, fatigue, and redness around the injection site
In connection with ongoing litigation, the FDA clarified that it does not intend to enforce violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act) related to tirzepatides compounding for a limited time to prevent unnecessary treatment disruptions: State-licensed pharmacies (Section 503A) : Permitted to compound, distribute, or dispense tirzepatide injections until February 18, 2025 (60 calendar days from todays announcement)
The Points system and fitness guidance help you build sustainable habits that complement the effects of GLP-1 medications, so youre not relying on injections alone to see progress
Relieve uncontrollably itchy skin Find out what may be causing the itch and what can bring relief
The dual action of Mounjaro has demonstrated a greater average weight loss in clinical trials, giving it a significant advantage in many cases